LumiraDx Limited


LumiraDx’s point of care testing (POCT) platform delivers test results in minutes that meet laboratory standards and clinical guidelines at significantly lower costs, including COVID-19 antigen and antibody tests.

Location: Waltham, MA
Business: Point of Care Diagnostic Platform
Invested in: 2016
Status: Merged with CA Healthcare Acquisition Corp. (SPAC); Public Listing September 2021